Tacrolimus ointment not associated with skin cancer risk

Theory on cutaneous immune responses led to long-term safety trials and reassuring answer

Related Videos
Related Content

Expert Tips on Alopecia Management From AAD 2023

March 20th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Hair Care, Hair Loss and the Overall Health of Black Women

March 18th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Methotrexate, Low-Dose Prednisone Efficacious in Alopecia Treatment

March 15th 2023

Microneedling Techniques Across the Globe

March 15th 2023

Expert Tips on Alopecia Management From AAD 2023

March 20th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Hair Care, Hair Loss and the Overall Health of Black Women

March 18th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Methotrexate, Low-Dose Prednisone Efficacious in Alopecia Treatment

March 15th 2023

Microneedling Techniques Across the Globe

March 15th 2023

Expert Tips on Alopecia Management From AAD 2023

March 20th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Hair Care, Hair Loss and the Overall Health of Black Women

March 18th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Methotrexate, Low-Dose Prednisone Efficacious in Alopecia Treatment

March 15th 2023

Microneedling Techniques Across the Globe

March 15th 2023
© 2023 MJH Life Sciences

All rights reserved.